PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression
暂无分享,去创建一个
Michael Müller | P. D. de Groot | G. Hooiveld | Michael Müller | M. Bünger | Heleen M de Vogel-van den Bosch | Hanneke Bosch-Vermeulen | Meike Bünger | Philip J de Groot | Guido JEJ Hooiveld | Hanneke Bosch-Vermeulen | Michael Müller
[1] M. Palacín,et al. CATs and HATs: the SLC7 family of amino acid transporters , 2004, Pflügers Archiv.
[2] J. Mandel,et al. Fenofibrate differently alters expression of genes encoding ATP‐binding transporter proteins of the peroxisomal membrane , 1997, FEBS letters.
[3] Michael Müller,et al. Gene expression of transporters and phase I/II metabolic enzymes in murine small intestine during fasting , 2007, BMC Genomics.
[4] D. Townsend,et al. The importance of glutathione in human disease. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[5] Kendall W Nettles,et al. Ligand control of coregulator recruitment to nuclear receptors. , 2005, Annual review of physiology.
[6] Peter J. Brown,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .
[7] Andreas Rolfs,et al. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins , 2004, Pflügers Archiv.
[8] S. Kersten,et al. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression. , 2006, Endocrinology.
[9] R. Ringseis,et al. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. , 2007, Pharmacological research.
[10] Igor Jurisica,et al. Integrated proteomic and transcriptomic profiling of mouse lung development and Nmyc target genes , 2022 .
[11] Ferdinando Palmieri,et al. The mitochondrial transporter family (SLC25): physiological and pathological implications , 2004, Pflügers Archiv.
[12] R. Tukey,et al. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. , 2000, Annual review of pharmacology and toxicology.
[13] W. Wahli,et al. Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.
[14] K. Inui,et al. Induction of intestinal peptide transporter 1 expression during fasting is mediated via peroxisome proliferator-activated receptor alpha. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[15] Vincent Laudet,et al. Overview of Nomenclature of Nuclear Receptors , 2006, Pharmacological Reviews.
[16] P Tso,et al. Intestinal lipid absorption and transport. , 2001 .
[17] J. Okita,et al. Cytochrome P450 4A fatty acid omega hydroxylases. , 2001, Current drug metabolism.
[18] G. Francis,et al. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.
[19] B. Staels,et al. Reduced cholesterol absorption upon PPARδ activation coincides with decreased intestinal expression of NPC1L1 Published, JLR Papers in Press, December 16, 2004. DOI 10.1194/jlr.M400400-JLR200 , 2005, Journal of Lipid Research.
[20] A. Wakamatsu,et al. SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. , 2005, Life sciences.
[21] E. Banoglu. Current status of the cytosolic sulfotransferases in the metabolic activation of promutagens and procarcinogens. , 2000, Current drug metabolism.
[22] J. Lehmann,et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] Jasmine Chen,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[24] E. Mazzon,et al. Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-α) in the development of inflammatory bowel disease in mice , 2004, Laboratory Investigation.
[25] B. Miroux,et al. A New Renal Mitochondrial Carrier, KMCP1, Is Up-regulated during Tubular Cell Regeneration and Induction of Antioxidant Enzymes* , 2005, Journal of Biological Chemistry.
[26] B. Lanne,et al. Beyond lipids, pharmacological PPARalpha activation has important effects on amino acid metabolism as studied in the rat. , 2007, American journal of physiology. Endocrinology and metabolism.
[27] Robin Hull,et al. A good practice guide to the administration of substances and removal of blood, including routes and volumes , 2001, Journal of applied toxicology : JAT.
[28] R. Weinshilboum,et al. Sulfotransferase molecular biology: cDNAs and genes , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] C. Thompson,et al. Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. , 1997, Archives of biochemistry and biophysics.
[30] K. Suckling,et al. Synthesis and coenzyme A-dependent esterification of cholesterol in rat intestinal epithelium. Differences in cellular localization and mechanisms of regulation. , 1983, The Journal of biological chemistry.
[31] K. Motojima,et al. PPARalpha agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine. , 2007, Biological & pharmaceutical bulletin.
[32] L. Kaminsky,et al. The small intestine as a xenobiotic-metabolizing organ. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[33] J. Falck,et al. Oxygenation of omega-3 fatty acids by human cytochrome P450 4F3B: effect on 20-hydroxyeicosatetraenoic acid production. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.
[34] L. Benet,et al. Active secretion and enterocytic drug metabolism barriers to drug absorption. , 2001, Advanced drug delivery reviews.
[35] W. Wahli,et al. The peroxisome proliferator‐activated receptor α regulates amino acid metabolism , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] M. Uldry,et al. The SLC2 family of facilitated hexose and polyol transporters , 2004, Pflügers Archiv.
[37] T. Pineau,et al. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha. , 2001, European journal of biochemistry.
[38] T. Langmann,et al. Structure, function and regulation of the ABC1 gene product , 2001, Current opinion in lipidology.
[39] F. Bredin,et al. Evidence for association of OCTN genes and IBD5 with ulcerative colitis , 2005, Gut.
[40] G. Gibbons,et al. Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice. , 2003, Journal of lipid research.
[41] P. Potin,et al. Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxidess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional four tables and six figures. Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300463-JLR200 , 2004, Journal of Lipid Research.
[42] F. Martel. Recent advances on the importance of the serotonin transporter SERT in the rat intestine. , 2006, Pharmacological research.
[43] S. Bowman,et al. Dietary-fat intake in the US population. , 1999, Journal of the American College of Nutrition.
[44] M. Hediger,et al. Primary structure and functional characterization of a high-affinity glutamate transporter , 1992, Nature.
[45] H. Rosing,et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[46] K. Tew,et al. GST function in drug and stress response. , 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[47] W. Sigurdson,et al. Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. , 2005, Biochemical and biophysical research communications.
[48] P. Watkins,et al. Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism. , 1999, Biochemical and biophysical research communications.
[49] P. Hunziker,et al. Basolateral aromatic amino acid transporter TAT1 (Slc16a10) functions as an efflux pathway , 2006, Journal of cellular physiology.
[50] Aurélien Grosdidier,et al. The Endocrine Disruptor Monoethyl-hexyl-phthalate Is a Selective Peroxisome Proliferator-activated Receptor γ Modulator That Promotes Adipogenesis* , 2007, Journal of Biological Chemistry.
[51] H. Sampath,et al. Polyunsaturated fatty acid regulation of genes of lipid metabolism. , 2005, Annual review of nutrition.
[52] D. Markovich,et al. The SLC13 gene family of sodium sulphate/carboxylate cotransporters , 2004, Pflügers Archiv.
[53] Danielson Pb,et al. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. , 2002 .
[54] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[55] G. Hooiveld,et al. Genome-wide analysis of PPARα activation in murine small intestine , 2007 .
[56] H. Waterham,et al. The peroxisomal ABC transporter family , 2007, Pflügers Archiv - European Journal of Physiology.
[57] Karim Benkirane,et al. Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension. , 2003, Hypertension.
[58] B. Spiegelman,et al. International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors , 2006, Pharmacological Reviews.
[59] W. Wahli,et al. Fluorescence Imaging Reveals the Nuclear Behavior of Peroxisome Proliferator-activated Receptor/Retinoid X Receptor Heterodimers in the Absence and Presence of Ligand*♦ , 2005, Journal of Biological Chemistry.
[60] J. Lehmann,et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. , 2000, Molecular cell.
[61] T. Murase,et al. Dietary alpha-linolenic acid-rich diacylglycerols reduce body weight gain accompanying the stimulation of intestinal beta-oxidation and related gene expressions in C57BL/KsJ-db/db mice. , 2002, The Journal of nutrition.
[62] T. Murase,et al. Dietary α-Linolenic Acid–Rich Diacylglycerols Reduce Body Weight Gain Accompanying the Stimulation of Intestinal β-Oxidation and Related Gene Expressions in C57BL/KsJ-db/db Mice , 2002 .
[63] W. Wahli,et al. Transcriptional regulation of metabolism. , 2006, Physiological reviews.
[64] S. Antonarakis,et al. The human sugar-phosphate/phosphate exchanger family SLC37 , 2004, Pflügers Archiv.
[65] J. Moscow,et al. Glutathione-related enzymes, glutathione and multidrug resistance , 2004, Cytotechnology.
[66] H. Lodish,et al. Identification of the major intestinal fatty acid transport protein. , 1999, Molecular cell.
[67] H. C. Lee,et al. Mitochondrial role in life and death of the cell. , 2000, Journal of biomedical science.
[68] J. Schuetz,et al. The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme* , 2004, Journal of Biological Chemistry.
[69] P. Danielson,et al. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. , 2002, Current drug metabolism.
[70] A. Rettie,et al. Positional specificity of rabbit CYP4B1 for omega-hydroxylation1 of short-medium chain fatty acids and hydrocarbons. , 1998, Biochemical and biophysical research communications.
[71] P. Tso,et al. Intestinal lipid absorption and transport. , 2001, Frontiers in bioscience : a journal and virtual library.
[72] Barry M. Forman,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .
[73] S. Kersten,et al. Peroxisome proliferator-activated receptor alpha target genes. , 2004, Cellular and molecular life sciences : CMLS.
[74] F. Oesch,et al. Epoxide hydrolases: structure, function, mechanism, and assay. , 2005, Methods in enzymology.
[75] P. Borst,et al. Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.
[76] S. Kersten,et al. Nutrigenomics: goals and strategies , 2003, Nature Reviews Genetics.
[77] J. Hoeijmakers,et al. Dysregulation of the Peroxisome Proliferator-Activated Receptor Target Genes by XPD Mutations , 2005, Molecular and Cellular Biology.
[78] Richard A Gibbs,et al. Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome. , 2004, Genome research.
[79] R. Gebhard,et al. In vivo regulation of canine intestinal 3-hydroxy-3-methylglutaryl coenzyme A reductase by cholesterol, lipoprotein, and fatty acids. , 1981, Journal of lipid research.
[80] K. Motojima,et al. PPARα Agonists Positively and Negatively Regulate the Expression of Several Nutrient/Drug Transporters in Mouse Small Intestine , 2007 .
[81] W. Roediger,et al. Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. , 1986, British journal of experimental pathology.
[82] H. Kondo,et al. Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice. , 2006, American journal of physiology. Endocrinology and metabolism.
[83] D. Waxman,et al. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. , 1995, Archives of biochemistry and biophysics.
[84] K. Siminovitch,et al. A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. , 2005, Gastroenterology.
[85] M. Relling,et al. Nomenclature for N-acetyltransferases. , 1995, Pharmacogenetics.
[86] D. Meredith,et al. The SLC16 gene family—from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond , 2004, Pflügers Archiv.
[87] C. Glass,et al. PPARs and molecular mechanisms of transrepression. , 2007, Biochimica et biophysica acta.
[88] Y. Kato,et al. Organic Cation/Carnitine Transporter OCTN2 (Slc22a5) Is Responsible for Carnitine Transport across Apical Membranes of Small Intestinal Epithelial Cells in Mouse , 2006, Molecular Pharmacology.
[89] J. Peters,et al. Polyunsaturated Fatty Acid Suppression of Hepatic Fatty Acid Synthase and S14 Gene Expression Does Not Require Peroxisome Proliferator-activated Receptor α* , 1997, The Journal of Biological Chemistry.
[90] C. Glass,et al. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators , 1998, Nature.
[91] S. Ferdinandusse,et al. PPAR alpha-activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. , 2007, Biochimica et biophysica acta.
[92] S. A. Tariq. Role of Ascorbic Acid in Scavenging Free Radicals and Lead Toxicity from Biosystems , 2007, Molecular biotechnology.
[93] R. Gainetdinov,et al. Mice lacking the dopamine transporter display altered regulation of distal colonic motility. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[94] M. Hayden,et al. ABCA1 Is Essential for Efficient Basolateral Cholesterol Efflux during the Absorption of Dietary Cholesterol in Chickens* , 2003, The Journal of Biological Chemistry.
[95] Luquan Wang,et al. Materials and Methods Figs. S1 to S4 Tables S1 and S2 References Niemann-pick C1 like 1 Protein Is Critical for Intestinal Cholesterol Absorption , 2022 .
[96] P. Hjemdahl,et al. Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans. , 1998, Clinical science.
[97] C. Liu,et al. Bacterial expression, purification, and characterization of a novel mouse sulfotransferase that catalyzes the sulfation of eicosanoids. , 1999, Biochemical and biophysical research communications.
[98] S. Gaetani,et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α , 2003, Nature.
[99] H. Daniel,et al. The SLC36 family: proton-coupled transporters for the absorption of selected amino acids from extracellular and intracellular proteolysis , 2004, Pflügers Archiv.
[100] A. Ciccodicola,et al. Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine‐loaded liposomes , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[101] E. Wright,et al. The sodium/glucose cotransport family SLC5 , 2004, Pflügers Archiv.
[102] J. Repa,et al. Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse. , 2007, Journal of lipid research.
[103] W. Wahli,et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. , 1997, Molecular endocrinology.
[104] T. Pineau,et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.
[105] S. Kersten,et al. Peroxisome proliferator-activated receptor α target genes , 2004, Cellular and Molecular Life Sciences CMLS.
[106] F. Field,et al. LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells DOI 10.1194/jlr.M100358-JLR200 , 2002, Journal of Lipid Research.
[107] J. G. Bieri. Second Report of the ad hoc Committee on Standards for Nutritional Studies , 1980 .
[108] A. Pajor. Sodium-coupled transporters for Krebs cycle intermediates. , 1999, Annual review of physiology.
[109] Michelle S. Scott,et al. Global Survey of Organ and Organelle Protein Expression in Mouse: Combined Proteomic and Transcriptomic Profiling , 2006, Cell.